Sigilon Therapeutics, Inc.
USD22.47
-0.59 (-2.56%)
CEO
Rogerio Vivaldi Coelho MBA
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.90
Prev. Close
$23.06
Day Low
$22.09
Day High
$23.08
52W Low
$3.77
52W High
$28.00
Market Cap
$0.06B
Volume
0.08M
| 1,718,493 |
| $14.92 |
| 11 Aug 2023 | Vivaldi Coelho Rogerio | director, officer: PRESIDENT AND CEO | D-Return | Disposed | 12,169 | $14.92 |
| 11 Aug 2023 | Vivaldi Coelho Rogerio | director, officer: PRESIDENT AND CEO | D-Return | Disposed | 35,382 | $14.17 |
| 11 Aug 2023 | Patel Kavita | director | D-Return | Disposed | 683 | $8.28 |
| 11 Aug 2023 | Patel Kavita | director | D-Return | Disposed | 683 | $9.92 |
| 11 Aug 2023 | Cole Douglas G. | director | D-Return | Disposed | 683 | $8.28 |
| 11 Aug 2023 | Cole Douglas G. | director | D-Return | Disposed | 683 | $9.92 |
| 11 Aug 2023 | Kowalsky Matthew Paul | CHIEF OF STAFF AND CLO | D-Return | Disposed | 1,925 | $14.92 |
| 11 Aug 2023 | Kowalsky Matthew Paul | CHIEF OF STAFF AND CLO | D-Return | Disposed | 12,690 | $14.17 |